StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

<< Previous

Bullboard Posts

Next >>

Post by kodiakupon Nov 28, 2020 3:39pm

886 Views

Post# 31995216

House Positions for C:SZLS YESTERDAY... and target price !!

House Positions for C:SZLS from 20201127 to 20201127

House	Bought	$Val	Ave	Sold	$Val	Ave	Net	$Net
2 RBC	289,558	210,592	0.727	58,190	40,684	0.699	231,368	-169,908
7 TD Sec	284,935	200,312	0.703	100,766	72,039	0.715	184,169	-128,273
83 Mackie	50,000	35,000	0.70	0			50,000	-35,000
53 Morgan Stanley	39,500	26,915	0.681	0			39,500	-26,915
1 Anonymous	276,878	187,898	0.679	248,125	172,764	0.696	28,753	-15,134
80 National Bank	44,392	31,237	0.704	24,015	16,977	0.707	20,377	-14,260
85 Scotia	0			250	175	0.70	-250	175
212 Virtu	490	358	0.731	910	652	0.716	-420	294
39 Merrill Lynch	1,500	1,070	0.713	2,000	1,430	0.715	-500	360
9 BMO Nesbitt	49,800	35,539	0.714	51,935	37,486	0.722	-2,135	1,947
18 Echelon	0			3,000	2,040	0.68	-3,000	2,040
5 Penson	30,295	21,588	0.713	34,902	24,972	0.715	-4,607	3,384
88 Credential	100	68	0.68	6,375	4,657	0.731	-6,275	4,589
19 Desjardins	5,000	3,350	0.67	27,719	20,012	0.722	-22,719	16,662
13 Instinet	14,000	9,760	0.697	44,000	29,860	0.679	-30,000	20,100
124 Questrade	8,540	5,797	0.679	39,900	28,429	0.713	-31,360	22,632
33 Canaccord	30,926	21,926	0.709	186,403	137,217	0.736	-155,477	115,291
79 CIBC	118,186	82,186	0.695	415,610	284,200	0.684	-297,424	202,014
TOTAL	1,244,100	873,596	0.702	1,244,100	873,594	0.702	0	-2

Analyst Price Target on TSE:SZLS

C$4.00

(440.54% Upside)

Based on 1 analyst offering 12 month price targets for StageZero Life Sciences Ltd in the last 3 months. The average price target is C$4.00 with a high forecast of C$4.00 and a low forecast of C$4.00. The average price target represents a 440.54% increase from the last price of C$0.74.